Ritonavir-boosted darunavir combined with raltegravir or tenofovir—emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

Authored by: Raffi F., Babiker A., Richert L, Molina JM, George EC, Antinori A, Arribas JR, Grarup J, Hudson F, Schwimmer C, Saillard J, Wallet C, Jansson PO, Allavena C., Van Leeuwen R, Delfraissy JF, Vella S, Chêne G, Pozniak A., for the NEAT001/ANRS143 Study Group
In: The Lancet , 2014, Aug 4 pii: S0140-6736(14)61170-3. doi: 10.1016/S0